TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0

CUSIP: 88163VAE9

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Debt / DBCV 0.250% 2/0
Market price (% of par)
130.14%
Total 13F principal
$423,191,262
Principal change
-$13,247,460
Total reported market value
$550,968,500
Number of holders
44
Value change
-$22,857,744
Number of buys
20
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 88163VAE9?
CUSIP 88163VAE9 identifies 88163VAE9 - TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q1 2016

As of 31 Mar 2016, TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by 44 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $423,191,262 in principal (par value) of the bond. The largest 10 bondholders included ZAZOVE ASSOCIATES LLC, Allianz Asset Management AG, WELLS FARGO & COMPANY/MN, AXA, VICTORY CAPITAL MANAGEMENT INC, ADVENT CAPITAL MANAGEMENT /DE/, MACKAY SHIELDS LLC, PRUDENTIAL PLC, CSS LLC/IL, and Invesco Ltd.. This page lists 44 institutional bondholders reporting positions for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.